Andrews, Louise M. http://orcid.org/0000-0001-8271-3685
de Winter, Brenda C. M.
Cornelissen, Elisabeth A. M.
de Jong, Huib
Hesselink, Dennis A.
Schreuder, Michiel F.
Brüggemann, Roger J. M.
van Gelder, Teun
Cransberg, Karlien
Article History
First Online: 26 October 2019
Compliance with Ethical Standards
:
: No funding was received for the conduct of this study or preparation of this article.
: Brenda C. M. de Winter has received Grant support from Astellas Pharma. Dennis A. Hesselink has received lecture and consulting fees from Astellas Pharma and Chiesi Farmaceutici Spa, as well as Grant support (paid to his institution) from Astellas Pharma, Chiesi Farmaceutici Spa, and Bristol Myers-Squibb. Teun van Gelder has received lecture and consulting fees from Astellas Pharma, Vitaeris, Aurinia Pharma, Roche Diagnostics, and Chiesi Farmaceutici Spa, as well as Grant support (paid to his institution) from Astellas Pharma and Chiesi Farmaceutici Spa. Elisabeth A. M. Cornelissen, Louise M. Andrews, Michiel F. Schreuder, Roger J. M. Brüggemann, and Karlien Cransberg have no conflicts of interest that are directly relevant to the content of this article.